Global Edema Treatment Market, By Type (Peripheral Edema, Pedal Edema, Lymphedema, Pulmonary Edema, Cerebral Edema, Macular Edema, Others), Treatment (Diuretic, Anti-allergic, Blood Thinners, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Edema Treatment Market Analysis and Size
The global edema treatment market is expected to witness significant growth during the forecast period. The edema treatment market is boosted by the adoption of unhealthy lifestyle such as obesity & smoking, intake of high blood pressure medications, premenstrual signs and symptoms, estrogen & NSAIDs and presence of several chronic diseases such as cirrhosis, kidney disease, weak or damage veins and protein deficiency. In addition, advances in treatment options and well-established healthcare facilities are some of the impacting factors for the growth of the edema treatment market. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global edema treatment market in the forecast period 2022-2029. The expected CAGR of global edema treatment market is tend to be around 7.50% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Edema is the type of condition in which swelling is caused by excess fluid trapped into the body tissue. It can affect especially the hands, legs, arms, feet and ankles. Edema can be the result of certain medication, pregnancy, certain diseases such as hypertension, kidney diseases and liver diseases. Symptoms of edema include swelling or puffiness of the tissue, stretched or shiny skin and increased abdominal size.
Edema Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Peripheral Edema, Pedal Edema, Lymphedema, Pulmonary Edema, Cerebral Edema, Macular Edema, Others), Treatment (Diuretic, Anti-allergic, Blood Thinners, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Mylan N.V. (U.S.), Fresenius Kabi AG (Germany), Hikma Pharmaceuticals PLC (Japan), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), Bristol Myers Squibb Company (U.S.) GSK Plc. (U.S.), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd (India), Aurobindo Pharma (India), Emcure (India)
|
|
Market Opportunities
|
|
Global Edema Treatment Market Dynamics
Drivers
- Rising Demand of Drugs
The rising demand of drugs is boosting the growth of the market. Mild edema can be cured without medication by levitating the affected limb higher than the heart. But in case of severe edema, it is treated with drugs that help rid excess fluid from the body in the form of urine. These drugs mostly include diuretics. This boosts the market growth.
Opportunities
- Rising Demand of Technologically Advanced Treatments
There are varied new techniques that allow a broad range of corrective nasal surgery That are performed. Alternatively, rise in the technologically advanced treatment methods, such as diuretic, anti-allergic, blood thinners are expected to drive the growth of the market. This factor boosts the opportunity of the edema treatment market.
- Increasing Demand for Retail Pharmacies
The rise in the number of drugs for transverse myelitis delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
- Lack of Awareness
Lack of patients awareness about the disease and its associated treatment can hamper the growth of the market.
- High Cost
The huge expenditure associated with these agents surely hamper the market growth.
This global edema treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global edema treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Edema Treatment Market Scope
The global edema treatment market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Peripheral Edema
- Pedal Edema
- Lymphedema
- Pulmonary Edema
- Cerebral Edema
- Macular Edema
- Others
Treatment
- Diuretic
- Anti-allergic
- Blood Thinners
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Edema Treatment Market Regional Analysis/Insights
The global edema treatment market is analysed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global edema treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing a positive growth for global edema treatment market throughout the forecasted period due to increased prevalence of hypertension, kidney and liver diseases and number of generic drugs.
North America dominates the market due to the presence of major manufacturers of the product, high R&D and healthcare expenditure and skilled professionals.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Edema Treatment Market Share Analysis
The global edema treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global edema treatment market.
Key players operating in the global edema treatment market include:
- Pfizer Inc (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Mylan N.V. (U.S.)
- Fresenius Kabi AG (Germany)
- Hikma Pharmaceuticals PLC (Japan)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Bristol Myers Squibb Company (U.S.)
- GSK Plc. (U.S.)
- Bayer AG (Germany)
- Sun Pharmaceutical Industries Ltd (India)
- Novartis AG (Switzerland)
- Aurobindo Pharma (India)
- Emcure (India)
SKU-